S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
The Next Big Crisis Is Here (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
The Next Big Crisis Is Here (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
The Next Big Crisis Is Here (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
The Next Big Crisis Is Here (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
OTCMKTS:INNVD

Innovus Pharmaceuticals - INNVD Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
$3.00
$3.00
52-Week Range
N/A
Volume
4,300 shs
Average Volume
9,592 shs
Market Capitalization
$7.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

INNVD stock logo

About Innovus Pharmaceuticals (OTCMKTS:INNVD) Stock

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality. The company also offers Beyond Human testosterone booster, ketones, krill oil, omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; UriVarx, a supplement for overactive bladder and urinary incontinence; PEVarx, a supplement for peak sexual performance; ProstaGorx, a supplement for prostate support; and FlutiCare, a nasal spray. In addition, its products include Apeaz for pain relief; AllerVarx for allergy relief; ArthriVarx for joint pain; Xyralid, a hemorrhoid cream; Can-C eye drop and eye care capsule; MZS, a melatonin formula to enhance sleep patterns; and Diabasens, a diabetic foot cream. The company's pipeline products comprise UriVarx for urinary tract infection; Xyralid suppositories for hemorrhoidal symptoms; GlucoGorx supplement, glucometer, lancing device, and GlucoGorx strip for blood sugar levels; Vesele and RecalMax nitric oxide strips. It markets and sells its products through commercial partners to primary care physicians, urologists, gynecologists, and therapists, as well as to other healthcare providers; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

Receive INNVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

INNVD Stock News Headlines

ACXP Acurx Pharmaceuticals, Inc.
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
BioCryst Pharmaceuticals Stock Is Tumbling: What's Going On?
Aurinia Pharmaceuticals Sees Higher 4Q Rev
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
INNV.PQ
Shuttle Pharmaceuticals Inc (SHPH)
See More Headlines

Receive INNVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

INNVD Company Calendar

Last Earnings
4/01/2019
Today
1/29/2023

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:INNVD
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Net Income
$-8,280,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$23.99 million
Book Value
$0.05 per share

Miscellaneous

Free Float
N/A
Market Cap
$7.07 million
Optionable
Not Optionable
Beta
2.89

Key Executives

  • Dr. Bassam B. Damaj (Age 51)
    Pres, CEO & Director
  • Mr. Ryan J. Selhorn CPA (Age 37)
    VP & CFO
  • Mr. Randy J. Berholtz (Age 58)
    Exec. VP of Corp. Devel., Gen. Counsel & Sec.
  • Mr. Christopher Stella
    VP of Operations
  • Mr. Robert C. Verfurth
    VP of Sales & Marketing













INNVD Stock - Frequently Asked Questions

How were Innovus Pharmaceuticals' earnings last quarter?

Innovus Pharmaceuticals Inc (OTCMKTS:INNVD) posted its quarterly earnings results on Monday, April, 1st. The company reported ($0.99) earnings per share for the quarter, topping the consensus estimate of ($1.11) by $0.12. The company had revenue of $4.75 million for the quarter, compared to the consensus estimate of $8.13 million. Innovus Pharmaceuticals had a negative trailing twelve-month return on equity of 682.54% and a negative net margin of 34.51%.

What is Innovus Pharmaceuticals' stock symbol?

Innovus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "INNVD."

How do I buy shares of Innovus Pharmaceuticals?

Shares of INNVD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How much money does Innovus Pharmaceuticals make?

Innovus Pharmaceuticals (OTCMKTS:INNVD) has a market capitalization of $0.00 and generates $23.99 million in revenue each year. The company earns $-8,280,000.00 in net income (profit) each year or ($4.16) on an earnings per share basis.

How can I contact Innovus Pharmaceuticals?

Innovus Pharmaceuticals' mailing address is 8845 Rehco Road, San Diego CA, 92121. The official website for the company is www.innovuspharma.com. The company can be reached via phone at 858-964-5123 or via email at ir@innovuspharma.com.

This page (OTCMKTS:INNVD) was last updated on 1/29/2023 by MarketBeat.com Staff